skip to Main Content
In Vitro Antiviral Testing

Well-characterized assays for a growing selection of viruses   Now Available! VSV-SARS-CoV2 Neutralization Assay

In Vitro Antiviral Testing

Assays for a wide selection of gram-positive and gram-negative bacteria


Now Available!  New Reagents for Coronavirus research    Full-Length Spike Protein, Soluble Receptor Binding Domain, Nucleocapsid Protein, and Polyclonal Antibodies.

Animal Models

Antiviral & antibacterial disease models – Immunogenicity testing, Pharmacokinetics & toxicity

Assay & Protein Services

Custom development, analysis and expression services

About IBT

The IBT Bioservices mission is to provide top client value by applying our infectious disease expertise, collaborative scientific interaction, and a flexible, cost-effective business model. The result is timely and relevant data for our clients’ needs.

Our scientists are leaders in their areas and can provide the highest level of expertise for your R&D programs. Read more about IBT.

Spotlight On:

Back To Top
×Close search

IBT Bioservices continues to conduct critical work as an essential business under the State of Maryland’s COVID-19 response directive. We have implemented a risk management plan and are continually monitoring the situation to ensure continuation of research according to public health services recommended best-practices for keeping our employees and the community safe. 

The IBT Bioservices team will continue to deliver high quality products and services for every project. If you have any questions contact us at